Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adial Pharmaceuticals Inc (NQ: ADIL )

2.050 USD +0.010 (+0.49%)
Streaming Delayed Price Updated: 1:44 PM EDT, Apr 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Adial Pharmaceuticals Inc

< Previous 1 2 3 Next >
Adial Founder and Chief Medical Officer Dr. Bankole Johnson Featured Guest on The Black News Channel
Discusses long-term effects of COVID-19 pandemic on mental health and addiction 
From GlobeNewswire News Releases
Adial Announces Management-Led $2,100,000 Above Market Private Placement at $3.00 Per Share
From GlobeNewswire News Releases
Adial Schedules Town Hall to Discuss Positive Updates Regarding Pharmaceutical Pipeline and Business Expansion
From GlobeNewswire News Releases
Adial Receives $1.425 Million in Net Proceeds from Exercise of Warrants
From GlobeNewswire News Releases
Adial Pharmaceuticals Achieves 50% Enrollment in ONWARD™ Phase 3 Trial
From GlobeNewswire News Releases
Adial to File Fast Track Application for AD04 with the FDA
From GlobeNewswire News Releases
BioMedNewsBreaks – Adial Pharmaceuticals Inc (NASDAQ: ADIL) Featured by M-Vest
From InvestorBrandNetwork
Adial Pharmaceuticals Closes Acquisition of Purnovate
From ACCESSWIRE
Adial Pharmaceuticals to Present at 23rd Annual ICR Conference
From ACCESSWIRE
Adial Pharmaceuticals Receives Notice of Allowance for Third U.S. Patent Covering AD04 for the Treatment for Opioid Use Disorder
From ACCESSWIRE
Adial Pharmaceuticals Appoints Dr. Jack Reich as Head of Regulatory
From ACCESSWIRE
Adial Pharmaceuticals Schedules Business Update Conference Call to Discuss Planned Acquisition of Purnovate and other Recent Developments
From ACCESSWIRE
Adial Pharmaceuticals Enters Agreement to Acquire Purnovate, a Developer of Potential Therapies for Non-Opioid Pain Reduction and Treatment of Addiction
From ACCESSWIRE
Adial Pharmaceuticals CEO Weighs in on the Alcohol Pandemic and Drunk Driving Over the Holidays; FOX31 Denver's Shaul Turner Interviews Bill Stilley
From ACCESSWIRE
InvestorNewsBreaks – M Vest Unveils List of ‘Latest Companies in the Spotlight’
From InvestorBrandNetwork
Adial Pharmaceuticals Lead Drug Candidate AD04 for Treatment of Alcohol Use Disorder Featured in Follow-up TV News Story
From ACCESSWIRE
Adial Pharmaceuticals Lead Drug Candidate AD04 for Treatment of Alcohol Use Disorder Featured on Multiple Television News Outlets
From ACCESSWIRE
Adial Pharmaceuticals Enters into Common Stock Purchase Agreement with Keystone Capital Partners to Support Strategic Opportunities and Future Growth Initiatives
From ACCESSWIRE
Adial Pharmaceuticals Provides Update on its ONWARD(TM) Pivotal Phase 3 Trial of AD04 for Treatment of Alcohol Use Disorder
From ACCESSWIRE
Diagnostic Testing Capabilities Improve in the Face of Global Turmoil
FinancialBuzz.com News Commentary 
From PR Newswire
AllPennyStocks.com News: The COVID-19 Pandemic Continues to Fuel Corporate Ingenuity
From SBWire - Latest Press Releases
Thinking about buying stock in Apache Corp, Ford, Norwegian Cruise Line, Bio-Path Holdings, or Adial Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for APA, F, NCLH, BPTH, and ADIL. 
From PR Newswire
Todos Medical Announces Distribution Agreement with Adial Pharmaceuticals to Market the FDA, EUA Authorized, Assure/FaStep Point-of-Care Covid-19 Antibody Tests
From GlobeNewswire News Releases
Todos Medical Announces Distribution Agreement with Adial Pharmaceuticals to Market the FDA, EUA Authorized, Assure/FaStep(R) Point-of-Care Covid-19 Antibody Tests
From ACCESSWIRE
Todos Medical Announces Distribution Agreement with Adial Pharmaceuticals to Market the FDA, EUA Authorized, Assure/FaStep Point-of-Care Covid-19 Antibody Tests
From NewMediaWire
Avalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point-of-Care Antibody Rapid Test Devices
Assure/Fastep® COVID-19 Point-of-Care Antibody Test is the First Test Granted FDA Emergency Use Authorization for Use with Fingerstick Blood Samples 
From GlobeNewswire News Releases
Avalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point-of-Care Antibody Rapid Test Devices
From ACCESSWIRE
Adial Pharmaceuticals Announces FDA Reactivation of its Investigational New Drug Application for AD04 in Alcohol Use Disorder
From ACCESSWIRE
Thinking about buying stock in Vaxart, iBio, ImmunoGen, Adial Pharmaceuticals, or Norwegian Cruise Line?
InvestorsObserver issues critical PriceWatch Alerts for VXRT, IBIO, IMGN, ADIL, and NCLH. 
From PR Newswire
Adial Pharmaceuticals Announces Sale of 10,000 COVID-19 Antibody Rapid Test Devices
From ACCESSWIRE
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.